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Abstract The association of cyclosporin A (CsA) immunosup- 
pression with inhibition of transcription factor-dependent lym- 
phokine gene activation formed the basis of our decision to inves- 
tigate nuclear-associated Cyp isoforms. Immunofluorescence mi- 
croscopy of mouse macrophages cell line with a monoclonal anti- 
body mAb7F1 raised against CypA shows a co-localisation of 
CypA in the nucleus and in the cytosol. Nuclear CypA binds to 
DNA in a zinc ion-dependent manner, in contrast to recombinant 
CypB. Peptidyl-prolyl cisltrans isomerase (PPIase) activity of 
nuclear CypA is inhibited by zinc ions. The zinc inhibited CypA 
does not bind cyclosporin A (CsA). We suggest hat nuclear Cyp 
in complex with zinc ions recognizes DNA sequences and is in- 
volved in transcription modulating processes. 
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1. Introduction 
Immunophilins (Cyclophilins, Cyp's) and FK506 binding 
proteins, (FKBP) have been found as binding proteins of the 
immunosuppressive drugs cyclosporin A (CsA) and FK506 (see 
refs. in [1-3]). Immunophi l in~trug complexes inhibit the pro- 
duction of interleukin-2 by inhibiting the calcium dependent 
phosphatase calcineurin [4]. In addition, inamunophilins have 
a variety of more general functions [5,6,7,8], e.g. peptidyl-prolyl 
cis/trans isomerases (PPIases, EC 5.2.1.8) [9], and specific bio- 
logical effects influencing cell activities in diseases [10 13]. It is 
likely that their divergent effects require alternative pathways 
of signal transduction. 
Subgroups (A, B and C) of  Cyp's have been identified and 
characterized in human macrophages and cell lines [14]. Under 
certain conditions cytoplasmic Cyp's may be released [15,16] 
and exert extracellular cytokine-like ffects [17,18]. Moreover, 
FKBP have recently been found in the nucleus of Jurkat T cells 
[19,20]. 
Using specific antibodies for immunofluorescence investiga- 
tions we found that CypA in contrast o CypB is localized in 
substantial amounts in the nucleus of mouse macrophages. The 
nuclear CypA binds DNA in a zinc-dependent manner. The 
specificity of  the localization and zinc binding of CypA may 
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suggest a functional role in the regulation of transcription proc- 
esses. 
2. Materials and methods 
2. L Cells' and cell cultures 
Mouse macrophage cell line H4-7 [21,22] were cultured in RPMI 
1640 (Gibco), supplemented with 10% fetal calf serum (Gibco) plus 1% 
penicillin and streptomycin (Sigma), 140 ¢tg/ml gentamycin (Biochrom, 
Berlin). For preparation of nuclei H4-7 cells were scraped off at a 
density of 1 x 10 7 cells per 100 mm Petri dish. 
2.2. Preparation of nuclei 
About 1 x 10 9 H4-7 cells were collected by centrifugation at200 x g, 
washed in cold phosphate-buffered saline (PBS), and resuspended in 0.3 
M SHM buffer (0.3 M sucrose, 25 mM HEPES, pH 7.2, 137 mM NaCI, 
5 mM KCI, 0.7 mM NaH2PO 4- 2HzO , 5 mM MgC10. Cells were dis- 
rupted and centrifuged for cytosolic and nuclear fractions according to 
the standard procedures [23,24]. The preparations were assessed using 
the cytosolic enzyme LDH: this approach yielded > 98% purity [25]. 
2.3. Purification of the nuclear cyclophilin from H4-7 cells 
The nuclear protein pellet was solubilized by ultrasound and loaded 
on a HiLoad 16/60 Superdex 75 Prep Grade gelfiltration column (Phar- 
macia) equilibrated with 20 mM HEPES (Sigma), pH 7.3, 0.1 M NaC1. 
The purification of Cyp was analyzed by measuring the PPIase activity 
as described [26]. Active fractions were pooled and dialyzed extensively 
against 10 mM Tricine, pH 8.0. The Cyp pool was applied to a TSK 
Affi-blue HR 5/5 column (Pharmacia) equilibrated with 10 mM Tricine, 
pH 8.0. Cyp eluted with a linear KC1 gradient (0-500 raM) in the same 
buffer. The protein was further separated on a C4-RP-HPLC chroma- 
tography column (Pharmacia, Sweden). After SDS-PAGE, the purified 
protein was transferred to PVDF membrane (Millipore) and subjected 
to amino acid sequence determination atToplab (Munich) on a Beck- 
man System Little Foot 3600 TD protein sequencer quipped with an 
on-line PTH derivatives system according to standard procedures. 
2.4. Antibodies and immunological techniques 
H4-7 macrophages, grown on coverslips, were washed three times in 
PBS and were fixed in freshly prepared 4% paraformaldehyde in PBS 
for 10 min at room temperature. After washing, the cells were permea- 
bilized with 50% acetone/methanol at -20°C for 10 min. The fixed and 
permeabilized cells were first blocked with 10% FCS in PBS for 30 min. 
Then they were incubated overnight at 4°C with the monoclonal anti- 
body mAb7F1 against CypA [27]. After washing, FITC-conjugated 
goat anti mouse IgG in PBS was applied to the cells for 2 h. For staining 
of DNA, Hoechst 33258 (Sigma) was added (final concentration of 5 
/tg/ml) together with the secondary antibodies. Finally, coverslips were 
washed, mounted in a solution of 10% (v/v) glycerol in PBS, sealed and 
observed under a Zeiss Axioskop microscope. 
2.5. Western blotting 
Samples to be analyzed were resuspended in Laemmli [28] sample 
buffer and subjected to 12% SDS-PAGE. Western blot analysis was 
performed as described [29] using anti-CypA mAb7F1 [27] and a poly- 
clonal anti-sera gainst CypB [30]. 
2.6. Determination of PPIase activity and inhibition assays 
The PPIase activity of cyclophilins was measured as described [26] 
using a Beckman DU 70 spectrophotometer with a thermostatted cell. 
For determination of the inhibition of the PPIase activity by ZnCIz 
(Merck) or other Me 2+ ions (stock solutions of Me 2+ salts were 100 mM) 
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the purified CypA was used. The reactivation ofthe PPIase activity with 
the specific zinc chelator 1,10-phenanthroline (Sigma) after inactivation 
with Zn 2+ was carried out as follows: a distinct concentration f purified 
Cyp was incubated with 1 mM ZnC12 for 15 rain. Inhibition of the 
PPIase activity was controlled by the enzymatic test with the synthetic 
substrate succinyl-Ala-Ala-Pro-Phe-4-nitroanilide. Then 1 raM, 2 raM, 
3 raM, or 5 mM 1,10-phenanthroline (stock solution 100 raM) were 
added, incubated on ice for 60 min, and PPIase activity was measured. 
2. 7. DNA-binding assay and immuno-dot blot 
Purified nuclear CypA (about 200/zg protein) or recombinant CypB 
[30] was mixed with about 50 mg double-stranded native DNA-cellu- 
lose affinity matrix from calf thymus (Sigma; 4 mg of double-stranded 
DNA per 1 g of solid phase) in 20 mM HEPES, pH 7.3 (DNA binding 
buffer). Using a series of Eppendorf-tubes, different samples were pre- 
pared adding ZnC12, DTT, EDTA at various concentrations. Forma- 
tion of complexes between protein and DNA-cellulose was allowed for 
3 h under rocking at 4°C. After 3 times washing, CypA bound to 
DNA-cellulose was eluted with different amounts of NaCI in the DNA 
binding buffer. To visualize the binding of CypA to DNA-cellulose, an 
immunoblot with mAb7F 1 was performed. 
2.8. "South- Western blot' analysis 
Purified nuclear and cytosolic CypA were mixed with Laemmli sam- 
ple buffer and not boiled. The proteins were separated in a 10% SDS- 
polyacrylamide g l (10/zg per lane), blotted onto a nitrocellulose sheet, 
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1 mM ZnCI2, 0.1% BSA) at 4°C. Total mouse macrophage genomic 
DNA was partially digested with Sau3AI (Gibco/BRL) to an average 
size of about 600 bp, labeled by Nick translation with [c¢-32p]dCTP [31] 
and incubated with the blot in the reaction buffer (20 mM Tris-HC1, 
pH 7.5, 1 mM ZnCI2) for 3 h at room temperature. Alternatively, the 
filter was incubated with mAb7F1 prior to probing with 32p-labeled 
DNA. The blot was washed five times, each for 10 min, in the reaction 
buffer at room temperature, dried, and autoradiographed. 
An identical blot was processed as described above, except hat the 
renaturation buffer and the reaction buffer contained 50 mM EDTA, 
10 mM DTT in place of 1 mM ZnCI2. 
3. Results 
3.1. Detection of  CypA in nuclei and cytosol of  macrophages 
Cyclophilin isoforms have been detected in different cell or- 
ganelles, e.g. endoplasmatic reticulum [32] and mitochondr ia 
[33]. We analyzed the cellular localization of Cyp's in the mouse 
macrophage cell line H4-7 by Western blot analysis using the 
ant i -CypA mAb7F1 and an anti-CypB polyclonal antiserum. 
CypA was detected in the nuclear subfraction (up to 15% of 
total CypA content of H4-7 cells), in contrast o a major local- 
ization in the cytosolic subfraction. CypB is restricted to the 








Fig. 1. (A) Localization of CypA to the nucleus by Western blot analysis. Nuclear (lanes 1, 3) and cytosolic lysates (lanes 2, 4) from mouse H4-7 
macrophages were assessed by immunoblot using a monoclonal anti-CypA antibody mAb 7F1 (lanes 1, 2) and a polyclonal anti-CypB antiserum 
(lanes 3, 4). The position of molecular weight markers (Sigma) on the side of the gel. (B) Immunofluorescence localization of CypA by a double-label 
experiment using DNA-staining Hoechst dye 33258 (a) and monoclonal nti-CypA antibody 7F1 (b). Mouse macrophages were grown on coverslips, 
fixed with paraformaldehyde, p rmeabilized with aceton/methanol and incubated first with mAB 7F1 and then with FITC-conjugated anti-mouse 
IgG. Note staining of the nuclei and the cytoplasm with mAb 7F1. (C) N-Terminal amino acid sequence alignment of mouse nuclear and cloned 
cytosolic CypA (Swissprot accession umber P17742). 
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confirmed by the cytosolic enzyme LDH. A simple cytosolic 
contamination of the nuclear subfraction was thereby excluded 
(data not shown). 
Further attempts to demonstrate he nuclear localization of 
CypA were made by indirect fluorescence staining of fixed H4-7 
cells with mAb7F1 and with Hoechst 33258 dye. Fig. 1B shows 
that CypA is located in the cytosol as well as in the nuclei. 
Staining of nuclear CypA correlates with DNA staining by 
Hoechst 33258 dye. 
CypA could be isolated from the nuclear fraction by a se- 
quence of gel filtration, affinity chromatography and subse- 
quent HPLC reversed phase separation. We obtained an 18 
kDa protein which shows PPIase activity and a high cross- 
reactivity with mAb7F1 in Western blot. Microsequencing of
the N-terminus revealed a 100% identity of the nuclear Cyp 
(nCyp) with CypA (Fig. 1C; for comparison see [14]). 
3.2. Zinc-dependent binding of CypA to DNA 
The data presented above prompted us to investigate the 
biological function of CypA in the nuclei of H4-7 cells. Re- 
cently, a FKBP25 was described in the nuclei of Jurkat T cells 
that binds to DNA [19]. The finding that CypA localizes to the 
nucleus uggested that nCyp might also interact with DNA. To 
address this possibility, nCyp was incubated with native DNA- 
cellulose affinity matrix. Preincubation of nCyp with 1 mM 
ZnC12 resulted in DNA-cellulose binding (Fig. 2A). No binding 
of nCyp to DNA-cellulose was detected in an untreated sample 
or in the presence of EDTA/DTT. High salt concentrations 
(500 mM NaCI) were required to elute the protein from DNA- 
cellulose. 
Further proof of a specific binding of nCyp to DNA was 
obtained by exposing nCyp from H4-7 cells to total genomic 
H4-7 DNA (partially digested with Sau3AI, labeled with [~- 
32p]dCTP) by means of a 'South-Western Blot' analysis. In the 
presence of ZnCI2, the DNA bound to nCyp (Fig. 2B, lane A). 
There was no DNA binding to this protein when ZnCI2 was 
displaced by DTT and EDTA (lane B). The identity of nCyp 
was confirmed by incubation with mAb7F1 prior to DNA 
probing to block the observed DNA binding (lane C). Specific- 
ity of CypA binding to DNA in the presence of ZnC12 was 
confirmed using recombinant CypB. Under these conditions 
CypB did not bind to DNA (lane D). 
3.3. Functional changes of  nCyp following zinc ion exposure 
PPIase activity of nCyp was completely inhibited by the 
immunosuppressive drug, cyclosporin A (CsA), but not by 
FK506 (data not shown). This enzymatic function of nCyp in 
H4-7 cells is inhibited by zinc ions (Fig. 3A). After 30 rain 
incubation with 1 mM ZnCI2, nCyp has a residual activity of 
about 28% compared to untreated control. Further exposure 
reduces the activity to almost zero. The specific Zn 2+ chelator 
1,10-phenanthroline was added to investigate the possibility of 
restoring enzyme activity. Nearly 90% of the starting activity 
was regained after 60 min treatment with 5 mM 1,10-phenan- 
throlin (Fig. 3B). Incubation of nCyp with Ca 2+, Co 2+, Ni 2+, 
Mg z+ had no effect on PPIase activity (Fig. 3A). 
Additionally, ZnC12 interferes with the binding sites involved 
in CsA binding of nCyp [34], i.e. we analyzed the [3H]CsA 
binding of nCyp after zinc treatment. Fig. 3C shows that zinc- 
inactivated nCyp loses the ability to bind CsA. 
Finally, zinc ion binding of nCyp was analyzed by a metal 
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Fig. 2. CypA binding to DNA. (A) Dots showing either the supernatant 
of the nuclear CypA or eluted fractions from DNA-cellulose matrices 
with 500 mM NaC1. Nuclear CypA was preincubated in the presence 
of zinc ions with DNA-cellulose. The supernatant or eluted material 
were subjected to a dot blot and analysed by immunostaining with mAb 
7F1. Lane 1 = nCyp in the absence of zinc; lane 2 = nCyp preincubated 
with 1 mM ZnC12; lane 3 = with 0.1 mM ZnCI2; lane 4 = with 10 mM 
DTT, 50 mM EDTA. (B) South-Western blot of nCyp from macroph- 
ages analysed for binding of 32p-labeled fragmented genomic DNA. 
After separation i  a 10% SDS-PAGE, proteins (5/zg) were transfered 
to a nitrocellulose filter and incubated in renaturation buffer. Blots 
were probed with 32p-labeled fragmented genomic DNA in the presence 
of either zinc ions (lane A) or EDTA and DTT (lane B). Lane C = pre- 
incubation with mAb 7F1 inhibits DNA binding. Note that purified 
CypB (lane D) does not bind to DNA in the presence of zinc ions. As 
a control in lane E, CypA was analysed in a Western blot with mAb 
7F1. 
ion affinity chromatography column. Salt was added to nCyp 
and starting buffer to exclude ion exchange ffects with the 
affinity matrix, nCyp bound to the column and could be eluted 
by a SDS-containing buffer. Samples were analyzed by Western 
Blot with mAb7F1 (data not shown). 
4. Discussion 
We identified two localizations of CypA in a mouse macro- 
phage cell line: the cytosol (major fraction) and the nuclei. In 
addition, we demonstrated that the nuclear CypA is a zinc- 
dependent DNA binding protein exhibiting the well-known 
PPIase activity only in the absence of zinc ions. 
The nCyp~inc omplex may bind to DNA unspecifically. In
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Fig. 3. Effect of Zn 2÷ on PPIase activity and CsA-binding. (A) Different concentrations ofzinc ions and other divalent cations were tested for their 
potency to inhibit PPIase activity of CypA. Bars represent the average of three experiments compared to untreated control (100%). (B) Reactivation 
of Zn 2+ inhibited nCyp and PPIase activity by 1,10-phenanthroline. PPIase activity of CypA was inhibited by preincubation with 1 mM ZnC12 for 
30 min, then 1,10-phenanthroline in increasing concentrations was added. After 60 min samples were tested for PPIase activity. Controls are untreated 
samples incubated for the same time. Bars indicate PPIase activity in percent compared to control. (C) CypA preincubated with (e) or without 1 
mM zinc ions (u) was analysed by the classical LH20 binding assay. The CypA-[3H]CsA complex eluted in the first three fractions, in contrast to 
retarded free [3H]CsA (fraction number > 10). 
accordance with this assumption, we estimate the amount of 
DNA bound to nCyp/zinc rather high as indicated by the strong 
signal in the autoradiography of Fig. 2B. One may also specu- 
late that the nCyp/zinc complex forms specific assemblies on 
target DNA elements together with eukaryotic transcription 
factors. Final proof for either assumption is lacking at present. 
Some recent reports showed another family of immunosup- 
pressive binding proteins, the FKBPs, to be located in the 
nuclear fraction, i.e. FKBP25 from T cells [19] and FKBP46 
from insect cells [35]. Both proteins are characterized asDNA 
binding proteins, the specificity of the binding remaining spec- 
ulative. Moreover, FKBP46 forms a proteimkinase complex 
involved in protein-protein teractions with basic chromatin 
proteins [35]. Also, Jin and Burakoff ound FKBP25 associated 
with casein kinase II and nucleolin in nuclear extracts of murine 
T cells [20]. 
PPIase activity of nCyp is inhibited by zinc ions in a dose- 
dependent manner. Apparently, zinc binding induces confor- 
mational changes of nCyp. We assume the binding site of zinc 
to be not within the CsA binding pocket of nCyp according to 
the published ata [34] and our computer modelling attempts 
(unpublished results). 
The observed reactivation of zinc inhibited PPIase activity 
by 1,10-phenanthroline suggests that the mechanism of zinc 
inhibition is a reversible process rather than a simple denatura- 
tion. Under physiological conditions and in steady-state it 
seems possible that a (nucleus) fraction of nCyp complexes 
zinc, possibly together with DNA, whereas another (cytosolic) 
fraction remains enzymatically active, working as PPIase. 
A recent report supports the assumption of nCyp binding to 
DNA indirectly [36]. It showed that CypA is involved in DNA 
fragmentation during apoptosis in rat thymocytes. The nucle- 
ase activity of CypA observed was found to be calcium depend- 
ent. Additionally, itwas shown that recombinant CypA, CypB, 
and CypC digested DNA unspecifically in the presence of cal- 
cium in a radioactive gel nuclease assay. This nuclease activity 
can be stimulate by CsA [36]. By contrast, he nuclease activities 
of Cyp's are inhibited by zinc ions. We suggest he following 
model to explain the at a first glance contradictory observa- 
tions: CypA can exist in two conformations - -  (i) a CsA bind- 
ing; and (ii) a 'not binding' isoform. In the CsA-binding confor- 
mation, CypA shows PPIase and nuclease activity. The CsA- 
'not binding' conformation is induced by zinc ion binding and 
characterized byDNA-binding and a loss of PPIase and nucle- 
ase activity. 
Therefore we assume that under normal growth conditions 
of mouse macrophages nCyp only binds to DNA in the pres- 
ence of zinc ions, whilst during apoptosis zinc binding is lost 
and nuclease activity is induced. Further studies will be neces- 
sary to analyze a possible shift in metal ion binding and a 
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change in subcellular localization of CypA during apoptosis in 
macrophages. 
Writing about zinc-mediated peptide loops interacting with 
nucleic acids, Luisi [37] postulated that zinc is compartmental- 
ized in a way guaranteeing the presence of this metal ion at the 
right place and time. CypA with its ambivalent function as 
PPIase and zinc binding protein might be involved in this home- 
ostasis. 
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